Ignite Creation Date:
2024-05-05 @ 9:16 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00856674
Status:
TERMINATED
Last Update Posted:
2010-06-02
First Post:
2009-03-04
Brief Title:
Safety Study of of Intravenous CCL2-LPM in Patients With IgA Nephropathy
Sponsor:
Osprey Pharmaceuticals USA Inc
Organization:
Osprey Pharmaceuticals USA Inc
Organization Data
Organization:
Osprey Pharmaceuticals USA Inc
Class:
INDUSTRY
Study ID:
OPL01-CCL2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Osprey Pharmaceuticals USA Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Barbara K Finck MD Senior Vice President and Chief Medical Officer
Old Organization:
Osprey Pharmaceuticals USA Inc